Skip to main content
. 2023 Dec 1;8(4):204–210. doi: 10.22540/JFSF-08-204

Table 2.

Assessment of sarcopenia.

Mean HGS, (SD)
 - Total (N=220) 16.9 (9.2)
 - Female (N=130) 12.5 (5.6)
 - Male (N= 90) 23.1 (9.7)
Mean CC, (SD)
 - Total (N=253) 33.7 (3.8)
 - Female (N=153) 33.2 (4.0)
 - Male (N=100) 34.5 (3.4)
Mean MAMC, (SD)
 - Total (N=247) 23.3 (3.3)
 - Female (N=148) 22.4 (3.1)
 - Male (N=99) 24.7 (3.1)
Mean gait speed, (SD)
 - Total (N=192) 0.71 (0.3)
 - Female (N=113) 0.69 (0.3)
 - Male (N=79) 0.73 (0.3)
Assessment of sarcopenia with HGS, CC or MAMC and gait speed N=220
 - No sarcopenia 71 (32.3%)
 - Probably sarcopenia 106 (48.2%)
 - Confirmed sarcopenia 27 (12.3%)
 - Severe sarcopenia 16 (7.2%)
SARC-F-Patient N=148
 - No sarcopenia 71 (48.0%)
 - Sarcopenia 77 (52.0%)
SARC-F-Proxy-Formal caregiver N=220
 - No sarcopenia 54 (24.6%)
 - Sarcopenia 166 (75.4%)
SARC-F-Proxy-Informal caregiver N=153
 - No sarcopenia 52 (34%)
 - Sarcopenia 101 (66%)

SD standard deviation, HGS Hand grip strength, CC calf circumferences, MAMC mid-arm muscle circumference. SARC-F score ≥ 4 points indicates sarcopenia.